ISPE

SEPTEMBER 14, 2023

Wager 14 September 2023 With a recent increase in interest and participation, the ISPE GAMP® Special Interest Group (SIG) focusing on Manufacturing Execution Systems (MES) has mapped out an ambitious number of subject areas to use as the basis for future publications, presentations, and best practice guidance documents.

Documentation 98

Documentation 98

Hospital Pharmacy Europe

NOVEMBER 2, 2023

They join existing members Mark Voce, chief strategy officer and deputy registrar, and Jonathan Bennetts, chief operating officer and deputy registrar, to form the new executive structure of the GPhC. I’m looking forward to joining the GPhC team in the new year,’ she said. ‘I

Hospitals 52

Hospitals 52

European Pharmaceutical Review

APRIL 29, 2024

The Cell and Gene Therapy Catapult (CGT Catapult) has appointed three new Non-Executive Directors to its board. Alongside this, Nicole is a Non-Executive Director of the Wellcome Sanger Genome Research Ltd and sits on the Health Data Ministerial Industry Group, CGT Catapult stated.

74

74

STAT

APRIL 16, 2024

Our choice today is the oh-so tasty hazelnut mocha. In an open letter , the hedge fund accuses Novavax’s leadership of squandering its “many significant competitive advantages and sizeable market opportunity” due to “self-inflicted problems” under the current team led by chief executive John Jacobs.

86

86

Omnicell

JANUARY 10, 2023

Jason Collins PharmD, Director of Inpatient Pharmacy, Owensboro Health Persistent labor shortages are making health system pharmacy executives rethink their operational and clinical options. We wanted a technology that would allow us to expand our operations while also ensuring our patients' safety and reducing staff stress.

Cart Fill 96

Cart Fill Omnicell Hospitals 96

pharmaphorum

FEBRUARY 11, 2021

Rob Wood has acquired a large minority stake in performance-io through a multimillion-pound deal that will see him join the specialist online performance marketing agency’s executive board. The agreement will see Lowe continue as performance-io’s CEO, with Wood joining Barrie Brien on its executive board.

113

113

Viseven

SEPTEMBER 5, 2023

On August 23-25, the Viseven team visited Manila, the capital of Philippines to attend PhilMedical Expo – an international exhibition on hospital, laboratory, pharmaceutical, and medical equipment and supplies. It was a great event.

Hospitals 52

Hospitals 52

STAT

NOVEMBER 11, 2022

This is, you may recall, our treasured signal to daydream about weekend plans. We are still setting our agenda, but for the moment, we expect to promenade with our official mascot, have another listening party with Mrs. Pharmalot and attend the latest installment in our “Let’s-see-them-before-they-go” concert series.

Vaccines 83

Vaccines 83

pharmaphorum

SEPTEMBER 9, 2022

The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs. Geoff Thorne has joined Fishawack Health (FH) as our new Chief Technology Officer.

52

52

European Pharmaceutical Review

FEBRUARY 23, 2024

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. AbbVie’s upcoming C-suite succession Robert has had “a tremendous impact” on AbbVie, according to Richard Gonzalez.

Hospitals 80

Hospitals 80

pharmaphorum

OCTOBER 20, 2022

Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies. How can we maximise marketing, sales, medical, access, and other teams’ efforts while making their jobs easier?

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Data Entry Documentation 97

Pharmaceutical Technology

MAY 25, 2023

Clover Biopharmaceuticals CEO and executive director Joshua Liang stated: “We are thrilled to partner with Kyuan Trade, which has a large and talented commercial team, a broad distribution network that extends across 31 provinces, municipalities and autonomous regions, and an excellent modern logistics network.

Vaccines 105

Vaccines 105

European Pharmaceutical Review

FEBRUARY 14, 2023

Johnson & Johnson ( J&J ) has announced that Dr John Reed, PhD, will become the company’s Executive Vice President of Pharmaceuticals, R&D on April 3, 2023. to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D. Dr. Reed will join Johnson & Johnson on April 3, 2023.

Hospitals 85

Hospitals 85

The FDA Law Blog

JANUARY 24, 2024

For nearly 20 years, ACI’s FDA Boot Camp has been the training grounds for life sciences attorneys and executives to master the fundamentals of FDA law and regulation. Join our co-chairs Kurt R. As such, we can offer our readers a special 10% discount. Karst (Director, Hyman, Phelps & McNamara, P.C.)

FDA 59

FDA Controlled Substances 59

ISPE

SEPTEMBER 8, 2023

This article outlines ISPE task teams created reports and a model to examine the challenges surrounding drug shortages, emergency preparedness, and the supply chain of active pharmaceutical ingredients (APIs). The ISPE Drug Shortages Team developed the model as a follow-up to the ISPE Drug Shortages Prevention Plan that was released in 2014.

Documentation 91

Documentation 91

Fuld

JULY 27, 2023

The latest edition of our Fuld insights newsletter brings you a curated collection of industry insights, cutting-edge trends, and strategic advice to help you navigate today’s complex business landscape and gain a competitive edge. In our second article, we voyage into the $14 billion market of electric vessels.

52

52

PQA

DECEMBER 15, 2023

PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality. We also highlight our members' perspectives on hypertension management and approaches to pharmacy reimbursement.

Community Pharmacies 59

Community Pharmacies Patient Care 59

InCrowd

DECEMBER 14, 2022

My responsibility—and that of my team—is to elevate Apollo, InCrowd, and SHG’s brands in the market, while ensuring a consistent message and market presence for each brand. Additionally, as a member of the Apollo Leadership Team, I contribute to major debates conducted, and decisions made at the executive level.

59

59

European Pharmaceutical Review

MARCH 8, 2023

As COMPASS Pathways continues to grow, Dr Malievskaia shared that currently, one third of the company’s board and executive team are female and women make up 64 percent of its team. Sue Stansfield, formerly our Head of Clinical Operations, inspired me hugely. Tell me a little about yourself and your role in innovation.

FDA 52

FDA Hospitals 52

European Pharmaceutical Review

JULY 7, 2022

“On behalf of the Board of Directors and our leadership team, I would also like to take this opportunity to thank Dr. Hafrun Fridriksdottir for over 25 years of service to Teva and its legacy companies. Brian Hughes replaces Hafrun Fridriksdottir who became Teva’s President of Global Generics R&D in 2017. .

Research Laboratories 90

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 90

PQA

MAY 3, 2024

There will be various networking opportunities, all of which will take place in our Industry Showcase, featuring organizations from across health care. We also highlight our members' perspectives on community health, specialty pharmacy and healthcare interoperability. Thank you to our sponsors and exhibitors.

Specialty Pharmacies 52

Specialty Pharmacies 52

pharmaphorum

JANUARY 17, 2023

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool.

98

98

Viseven

OCTOBER 3, 2023

Viseven and Veeva have been partners for many years, providing advanced technology and content expertise to pharma and life sciences businesses and agencies of all sizes, and it was a big honor and privilege for the Viseven team to be at the event and make its own contribution to the evolution of biopharma digital marketing.

52

52

pharmaphorum

DECEMBER 14, 2022

Morgan kicks off new PE team. November saw the launch of a new private equity team in life sciences at J.P. The team will be led by Dr Stephen Squinto in the role of chief investment officer, backed up by co-managing partners Dr Gaurav Gupta and Anya Schiess. Check out our other roundups for pharma and pharma supplier news.

98

98

Pharmaceutical Technology

MARCH 15, 2023

The Parker Review committee has announced new targets for improving the ethnic diversity of FTSE 350 senior management teams and large private businesses in the UK, which include pharma companies. Ethnic minority executives will occupy these positions during that period.

52

52

pharmaphorum

JULY 13, 2021

The regulated content and labeling software firm has made three new customer-facing appointments and created a brand-new Customer Experience Team to provide enhanced, end-to-end customer support for medical device and clinical trial organizations.

Customer Service 52

Customer Service Labelling Packaging 52

Pharmaceutical Technology

APRIL 20, 2023

Roquette has appointed a new team of research scientists and formulation experts to offer guidance to the facility and to the company’s global pharmaceutical R&D activities. The team is led by Dr Vinod Tuliani, who will look after Roquette’s long-term scientific strategy and its execution across the firm’s pharma sciences unit.

Dosage 52

Dosage 52

pharmaphorum

OCTOBER 31, 2022

. “We are proud to be not just one of the few AI-driven biotech companies to have made it to the clinical stage, but also one of the first to bring forward a novel clinical compound against a novel target, that was entirely discovered and developed internally on our platform,” said Zhang, who acts as Verge’s chief executive.

Compounding 134

Compounding 134

pharmaphorum

JUNE 24, 2021

Silver will lead the McCann Health New York executive leadership team and join the McCann Health North America leadership Team. McCann Health New York has promoted general manager Matt Silver to the role of president. . He will report to McCann Health North America’s president, Jim Joseph.

57

57

pharmaphorum

APRIL 26, 2022

French drugmaker wants the efficiency of its manufacturing operations to go up a gear, and has joined forces with Formula One racing team McLaren to make it happen. “I see a lot of commonalities in our shared values to stretch, with courage and determination, so we can maximise performance and operational excellence.

92

92

Pharmaceutical Technology

MAY 10, 2023

Gilead Sciences research executive vice-president Flavius Martin stated: “The team at XinThera has developed research assets with the potential to target the DNA damage repair pathway in treating cancer and direct the body’s immune response in inflammatory diseases, both of which may improve outcomes for people living with these diseases.

Immunization 52

Immunization 52

pharmaphorum

MARCH 7, 2022

News of the cash injection came as ArrePath also announced the appointment of ex-Evotec head of anti-infectives – Dr Lloyd Payne – as its president and chief executive. At Evotec he was responsible for a 200-strong scientific team working on drug discovery tools used to discover new anti-infective medicines.

Compounding 136

Compounding 136

pharmaphorum

DECEMBER 17, 2020

This provides the catalyst for an AI-driven acceleration in drug discovery and the team has just won a significant Innovate UK grant in order to prove that it works. Our newsflows are full of details of AI applications in process automation, image analysis and computational chemistry.

Compounding 126

Compounding Immunization 126

European Pharmaceutical Review

MAY 11, 2023

“The unveiling of Revvity is the capstone of a nearly year-long journey that has transformed who we are and reinforces why our work matters,” commented Prahlad Singh, President and Chief Executive Officer of Revvity. “At At Revvity, we are united with our customers to impact health across the lifespan.

76

76

Hospital Pharmacy Europe

JANUARY 4, 2024

The chief pharmaceutical officer (CPhO) for England and General Pharmaceutical Council (GPhC) have warned that pharmacy teams will experience challenging circumstances over the coming weeks and months, due to high demand, staff shortages, sickness and industrial action.

Patient Care 52

Patient Care Hospitals 52

Pharmaceutical Technology

AUGUST 9, 2022

Albumedix CEO Jonas Møller and its executive management team will continue to lead the company. Albumedix will also add important formulation excipients to our vaccine production solutions, allowing us to expand our existing customer relationships and forge new ones.”.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

NOVEMBER 17, 2022

Horizon Therapeutics research and development executive vice-president Elizabeth Thompson said: “Collaboration is essential to move science forward, and we are very pleased to begin working with Johns Hopkins University. “By

52

52